Regen is focused on identifying undervalued regenerative medicine applications in the stem cell/immunotherapy space and rapidly advancing these technologies through pre clinical and Phase I/II clinical trials. Currently the Company is developing products treating blood disorders using small molecules and gene silencing DiffronC , treating cancer with immunotherapy dCellVax , modulating key molecular processes in cancer stem cell through its patented molecular targeting approaches BORIS , and repairing damaged bone marrow in patients with aplastic anemia and chemotherapy/radiotherapy treated cancer patients HemaXellerate .
Quote | Regen BioPharma Inc (OTCMKTS:RGBP)
Last: | $0.31 |
---|---|
Change Percent: | 0.0% |
Open: | $0.4 |
Close: | $0.31 |
High: | $0.4 |
Low: | $0.31 |
Volume: | 5,155 |
Last Trade Date Time: | 07/19/2024 03:00:00 am |
News | Regen BioPharma Inc (OTCMKTS:RGBP)
Regen BioPharma, Inc. Selects Contract Research Organization to Assist in DuraCAR Experiments PR Newswire SAN DIEGO , Nov. 16, 2023 /PRNewswire/ -- Regen BioPharma, Inc. (OTC PINK: RGBP) (OTC PINK: RGBPP) The Company has announced that after interviewing sev...
Regen BioPharma, Inc. CEO Outlines Future Steps in CAR T Program PR Newswire SAN DIEGO , Nov. 14, 2023 /PRNewswire/ -- Regen BioPharma, Inc. (OTC PINK: RGBP) (OTC PINK: RGBPP) has previously discussed initiation of its DuraCAR CAR T-cell therapeutic ( http...
Message Board Posts | Regen BioPharma Inc (OTCMKTS:RGBP)
Subject | By | Source | When |
---|---|---|---|
it is a bad idea 99.9%of the time | archilles | investorshub | 05/01/2023 3:19:58 AM |
Time already spoke. I even forgot I had | Fdc4 | investorshub | 04/30/2023 10:36:10 PM |
29 year scamming. | Huggy Bear | investorshub | 04/29/2023 4:08:56 PM |
Did he say that when there were 5B | goodietime | investorshub | 04/26/2023 9:37:15 PM |
$RGBP didn't ceo say he wanted $5 for | okwife | investorshub | 04/26/2023 5:16:43 PM |
News, Short Squeeze, Breakout and More Instantly...
Regen BioPharma, Inc. Selects Contract Research Organization to Assist in DuraCAR Experiments PR Newswire SAN DIEGO , Nov. 16, 2023 /PRNewswire/ -- Regen BioPharma, Inc. (OTC PINK: RGBP) (OTC PINK: RGBPP) The Company has announced that after interviewing sev...
Regen BioPharma, Inc. CEO Outlines Future Steps in CAR T Program PR Newswire SAN DIEGO , Nov. 14, 2023 /PRNewswire/ -- Regen BioPharma, Inc. (OTC PINK: RGBP) (OTC PINK: RGBPP) has previously discussed initiation of its DuraCAR CAR T-cell therapeutic ( http...
Regen BioPharma, Inc. Receives Second Phase Confirmatory Data on its Duracar CAR-T Cell Therapy Program PR Newswire Autoimmunity to be Targeted SAN DIEGO , Oct. 25, 2023 /PRNewswire/ -- Regen BioPharma, Inc. (OTC PINK: RGBP) (OTC PINK: RGBPP) ...